Publications by authors named "Kitty Cook"

Claim this Profile
A
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy.
Christina Baik, Sylvia Lee, Kitty Cook, Sarah Wallace, Rebecca Wood

Cancer Treat Res Communยท February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis